Brief: Can-Fite To Conduct Investor Meetings During The J.P. Morgan Healthcare Conference

Can Fite Biopharma

10/01/2022 12:43

Jan 10 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE TO CONDUCT INVESTOR MEETINGS DURING THE J.P. MORGAN HEALTHCARE
CONFERENCE
    * CAN FITE - IN Q1 OF 2022, EXPECT TO COMMENCE PATIENT ENROLLMENT IN PIVOTAL
PHASE
III TRIAL FOR NAMODENOSON IN TREATMENT OF PATIENTS WITH ADVANCED HCC
    * CAN FITE BIOPHARMA LTD - FDA AND EMA HAVE AGREED WITH DESIGN OF
471-PATIENT
STUDY

Source text for Eikon:  ID:nBw43gzcma 
Further company coverage:  CANF.TA